Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tehran Hepatitis Center is a prominent private medical and research institution located in Tehran, Iran, specializing in the management of viral hepatitis and chronic liver diseases. Established by Professor Seyed Moayed Alavian, the center has become a regional leader in hepatology, offering comprehensive services ranging from advanced diagnostics to specialized outpatient care. It is particularly recognized for its expertise in treating Hepatitis B and C, utilizing modern antiviral therapies and non-invasive liver assessment technologies like FibroScan. Beyond clinical practice, the center is a major contributor to global medical literature through its affiliation with the Middle East Liver Diseases Center and the publication of the 'Hepatitis Monthly' journal. The organization also spearheads public health campaigns and educational initiatives aimed at reducing the burden of liver disease in the Middle East. Its research activities focus on the epidemiology, natural history, and therapeutic outcomes of liver infections within the Iranian population.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tehran Hepatitis Center.